China $2.1 Billion Chemical & Healthcare Materials Company Qingdao Gon Technology Hong Kong Secondary Listing IPO Share Price Increased +11.5% on Day 1 Trading (4/2/26: IPO Price: HKD 36, Closing HKD 40.16) & Raised $129 Million in IPO, Founded in 2000, Controlling Shareholders are CEO Wang Aiguo, Xu Bo & Xinghao Investment (Controlled by Xu Bo)
5th February 2026 | Hong Kong
China chemical & healthcare materials company Qingdao Gon Technology ($2.1 billion market value) Hong Kong secondary listing IPO share price increased +11.5% on day 1 trading (4/2/26: IPO Price: HKD 36, Closing HKD 40.16), raising $129 million in the IPO. In 2026 January, Qingdao Gon Technology Hong Kong secondary listing IPO was raising $128 million, with expected IPO listing on 4th February 2026. Qingdao Gon Technology was founded in 2000. Qingdao Gon Technology controlling shareholders are CEO Wang Aiguo, Xu Bo & Xinghao Investment (Controlled by Xu Bo). Qingdao Gon Technology – Qingdao Gon Technology Co., Ltd., established on December 22, 2000, with a registered capital of RMB 271.25 million, is located in Qingdao Chengyang District Qingda Industrial Park. It is a listed company on the A-share market (stock abbreviation: Gon Shares, stock code: 002768.SZ) and one of the first batch of high-tech enterprises. With the vertically integrated industrial platform of Gon system as the core, the company aims for long-term scale benefits, centers on technological innovation, and positions petrochemicals and healthcare industries as dual wings. Implementing the “one core, two wings” development strategy, it integrates the R&D, production, services, and applications of the upstream and downstream industrial chains, promoting the rapid development of various business sectors. The company continuously optimizes its industrial structure and has preliminarily developed into a vertically integrated industrial cluster of new chemical materials including green petrochemicals, organic polymer modification, organic polymer composites, artificial turf, degradable materials, light-emitting materials, and lightweight structural components for new energy vehicles. At the same time, it holds a controlling stake in Dongbao Bio-Tech, a listed company in the collagen field (stock code: 300239), with products including gelatin, empty capsules, collagen, plasma substitute gelatin, dual-protein dietary fiber, and medical beauty products, forming a comprehensive enterprise group in the subdivision of the healthcare industry focusing on medical, beauty, health, and food. In recent years, through extending the industrial chain, connecting the supply chain, Strengthening the Innovation Chain,enhancing the value chain, and constructing the ecological chain, the company continuously integrates market resources. By leveraging the resource development advantages of the vertically integrated platforms in petrochemicals and healthcare industries, it actively provides customers with multi-category products and high-quality services, constantly builds a matrix-style industrial cluster production base, promotes the layout of the petrochemical industry through “new materials +” and empowers the multi-dimensional development of the healthcare industry through “collagen +”, continuously strengthening the company’s comprehensive strength.
“ China $2.1 Billion Chemical & Healthcare Materials Company Qingdao Gon Technology Hong Kong Secondary Listing IPO Share Price Increased +11.5% on Day 1 Trading (4/2/26: IPO Price: HKD 36, Closing HKD 40.16) & Raised $129 Million in IPO, Founded in 2000, Controlling Shareholders are CEO Wang Aiguo, Xu Bo & Xinghao Investment (Controlled by Xu Bo) “
![](https://www.caproasia.com/wp-content/uploads/2025/08/Air-Charter-Service-728x90-1.png")
China $2.1 Billion Chemical & Healthcare Materials Company Qingdao Gon Technology Hong Kong Secondary Listing IPO to Raise $128 Million with Expected IPO Listing on 4th February 2026, Founded in 2000, Controlling Shareholders are CEO Wang Aiguo, Xu Bo & Xinghao Investment (Controlled by Xu Bo)
31st January – China chemical & healthcare materials company Qingdao Gon Technology ($2.1 billion market value) Hong Kong secondary listing IPO is raising $128 million, with expected IPO listing on 4th February 2026. Qingdao Gon Technology was founded in 2000. Qingdao Gon Technology controlling shareholders are CEO Wang Aiguo, Xu Bo & Xinghao Investment (Controlled by Xu Bo). Qingdao Gon Technology – Qingdao Gon Technology Co., Ltd., established on December 22, 2000, with a registered capital of RMB 271.25 million, is located in Qingdao Chengyang District Qingda Industrial Park. It is a listed company on the A-share market (stock abbreviation: Gon Shares, stock code: 002768.SZ) and one of the first batch of high-tech enterprises. With the vertically integrated industrial platform of Gon system as the core, the company aims for long-term scale benefits, centers on technological innovation, and positions petrochemicals and healthcare industries as dual wings. Implementing the “one core, two wings” development strategy, it integrates the R&D, production, services, and applications of the upstream and downstream industrial chains, promoting the rapid development of various business sectors. The company continuously optimizes its industrial structure and has preliminarily developed into a vertically integrated industrial cluster of new chemical materials including green petrochemicals, organic polymer modification, organic polymer composites, artificial turf, degradable materials, light-emitting materials, and lightweight structural components for new energy vehicles. At the same time, it holds a controlling stake in Dongbao Bio-Tech, a listed company in the collagen field (stock code: 300239), with products including gelatin, empty capsules, collagen, plasma substitute gelatin, dual-protein dietary fiber, and medical beauty products, forming a comprehensive enterprise group in the subdivision of the healthcare industry focusing on medical, beauty, health, and food. In recent years, through extending the industrial chain, connecting the supply chain, Strengthening the Innovation Chain,enhancing the value chain, and constructing the ecological chain, the company continuously integrates market resources. By leveraging the resource development advantages of the vertically integrated platforms in petrochemicals and healthcare industries, it actively provides customers with multi-category products and high-quality services, constantly builds a matrix-style industrial cluster production base, promotes the layout of the petrochemical industry through “new materials +” and empowers the multi-dimensional development of the healthcare industry through “collagen +”, continuously strengthening the company’s comprehensive strength.
Caproasia Users
- Manage $20 million to $30 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2026 Investment Day
- March - Hong Kong
- March - Singapore
- April - Hong Kong
- April - Singapore
- July - Hong Kong
- July - Singapore
- Sept- Hong Kong
- Sept - Singapore
- Oct- Hong Kong
- Nov - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Institutional Investor Summit
- The Investment / Alternatives Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit
